Autoantibodies Against Cell Surface Receptors in Adults Living With Obesity
Looks at whether certain autoantibodies are linked to obesity and obesity-related diseases.
Plain-language title generated from the registry record
Registry title: The Role of Autoantibodies Against G-protein Coupled Receptors in Obesity
Key facts
- Where
- Esbjerg, DenmarkSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 60 years old?
Source: NCT07542327, who can take part
Where in Denmark
- University Hospital of Southern Denmark, EsbjergEsbjerg, DenmarkNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Claus Bogh Juhl
- Trial code
- NCT07542327
- Record updated
- 24 April 2026
- Original description
The purpose of this study is to explore if GPCR-autoantibodies:Read full original descriptionShow less
The Role of Autoantibodies Against G-protein Coupled Receptors in Obesity
The purpose of this study is to explore if GPCR-autoantibodies:
1. are pressent in people living with obesity, and are associated with degree of obesity 2. if it is associated with obesity related diseases
Inclusion: Inhabitant in the Region of Southern Denmark; BMI above 30kg/m2; age between 18 and 60 years.
Exclusion: individuals previously treated with GLP-1RA medication for any indication; Individuals who have previously undergone bariatric surgery; Individuals with type 1 diabetes.